Research Paper Volume 13, Issue 3 pp 3536—3553

Identification of HIPK3 as a potential biomarker and an inhibitor of clear cell renal cell carcinoma


Figure 4. HIPK3 correlated with various clinicopathological parameters in ccRCC tissues. The mRNA levels of HIPK3 were compared in different clinicopathological parameters: (A) overall survival status, (B) disease free status cancer versus paired para-cancer, (C) M stage, (D) and (E) T stage, (F) and (G) grade, (H) and (I) TNM stage. S: TNM stage; HIPK, Homeodomain interacting protein kinases. *P<0.05, **P<0.01, ***P<0.001 and ****P<0.0001.